A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years
old) with major depressive disorder
Duloxetine 60 mg QD and placebo variable-duration, placebo lead-in period 9 weeks in the
acute treatment phase
- You must be able to visit the doctor's office for clinic visits, tests, and
- You must have been diagnosed with major depression, and have had at least one other
episode in the past.
- You have a current or previous major psychiatric disorder other than depression, such
as bipolar disorder, schizophrenia, or other psychotic disorder.
- You have taken a drug within the last 30 days that has not been approved for use by